Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G2A

Human [protein ADP-ribosylargenine] hydrolase ARH1 in complex with ADP-HPM

Summary for 6G2A
Entry DOI10.2210/pdb6g2a/pdb
Descriptor[Protein ADP-ribosylarginine] hydrolase, Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol, MAGNESIUM ION, ... (6 entities in total)
Functional Keywordsadp-ribosylation, adp-ribose, adprh, adp-ribosylhydrolase, hydrolase, arh1, adp-hpm
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight41472.32
Authors
Ariza, A. (deposition date: 2018-03-22, release date: 2018-11-28, Last modification date: 2024-01-17)
Primary citationRack, J.G.M.,Ariza, A.,Drown, B.S.,Henfrey, C.,Bartlett, E.,Shirai, T.,Hergenrother, P.J.,Ahel, I.
(ADP-ribosyl)hydrolases: Structural Basis for Differential Substrate Recognition and Inhibition.
Cell Chem Biol, 25:1533-1546.e12, 2018
Cited by
PubMed Abstract: Protein ADP-ribosylation is a highly dynamic post-translational modification. The rapid turnover is achieved, among others, by ADP-(ribosyl)hydrolases (ARHs), an ancient family of enzymes that reverses this modification. Recently ARHs came into focus due to their role as regulators of cellular stresses and tumor suppressors. Here we present a comprehensive structural analysis of the enzymatically active family members ARH1 and ARH3. These two enzymes have very distinct substrate requirements. Our data show that binding of the adenosine ribose moiety is highly diverged between the two enzymes, whereas the active sites harboring the distal ribose closely resemble each other. Despite this apparent similarity, we elucidate the structural basis for the selective inhibition of ARH3 by the ADP-ribose analogues ADP-HPD and arginine-ADP-ribose. Together, our biochemical and structural work provides important insights into the mode of enzyme-ligand interaction, helps to understand differences in their catalytic behavior, and provides useful tools for targeted drug design.
PubMed: 30472116
DOI: 10.1016/j.chembiol.2018.11.001
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon